(PRWEB) July 08, 2013
The Rottenstein Law Group LLP, a law firm that represents hundreds of surgical mesh plaintiffs, looks forward to the first bellwether trial in the federal consolidation of cases against C.R. Bard for injuries allegedly caused by that company’s transvaginal mesh products. That bellwether trial—Cisson v. C.R. Bard Inc., 2:11-cv-00195 (S.D.W.Va.)—was set to begin on July 8, according to Bloomberg.*
E-mail recently uncovered as part of the customary pre-trial exchange of documents in that bellwether case shows that executives at Bard allegedly knew that the resin-based plastic that was being used in the company’s Avaulta transvaginal mesh products was not fit for human implantation, according to the Bloomberg story.
“We’re optimistic that the first bellwether trial in the MDL against Bard in West Virginia federal court will yield an encouraging result for vaginal mesh victims everywhere,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP.
The last trial against Bard for vaginal mesh injuries—a state-court case in California—resulted in a $5.5 million verdict in favor of Christine Scott, who had received an Avaulta mesh implant, according to Bloomberg.** That case was tried without the benefit of the e-mail that was uncovered last week (Scott v. Kannappan, S-1500-CV-266034-WDE, Superior Court for Kern County, California, Bakersfield).
The Rottenstein Law Group LLP encourages those who believe they have suffered from the Avaulta’s alleged side effects to visit its FAQ page for quick answers to their questions about the device, its side effects and lawsuits. If there are additional questions, those looking for more information can use the contact form to get in touch with a transvaginal mesh lawyer.
*bloomberg.com/news/2013-06-26/bard-used-mesh-plastic-found-unfit-for-humans-by-supplier.html (June 26, 2013)
**bloomberg.com/news/2012-07-24/bard-must-pay-5-5-million-over-vaginal-mesh-implants.html (July 24, 2012)
About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com